Q32 Bio (QTTB) Balance Sheet: Assets & Liabilities

Q32 Bio (QTTB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Q32 Bio reported total assets of $61.78M and total liabilities of $19.76M. Shareholders' equity was $42.01M, up 640.3% from $5.67M a year earlier. Total debt stood at $9.71M against $48.30M in cash and short-term investments, a net cash position of $38.59M. That puts debt-to-equity at 0.23, compared with 2.23 a year earlier.

Q32 Bio Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Q32 Bio Inc. (QTTB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	48.30	77.97	25.62	43.89	108.38	217.43	53.77	38.22	51.57
Short-Term Investments	0.00	0.00	0.00	141.04	47.49	0.00	208.61	176.52	78.08
Cash & Short-Term Investments	48.30	77.97	25.62	43.89	155.87	217.43	262.39	214.74	129.66
Accounts Receivable	5.39	0.56	0.76	1.06	0.00	0.40	0.40	0.80	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.02	0.40	0.08	0.15	36.04	1.73	3.79	6.15	1.94
Total Current Assets	55.05	81.88	28.72	46.85	191.91	219.56	266.58	221.69	131.60
Non-Current Assets
Property, Plant & Equipment (Net)	6.08	7.09	8.08	9.17	17.86	42.90	42.72	35.64	3.15
Long-Term Investments	0.65	2.60	5.65	25.81	1.95	1.27	1.27	1.77	1.77
Other Non-Current Assets	0.65	0.65	5.67	5.76	0.00	0.00	0.00	0.00	1.00
Total Non-Current Assets	6.73	10.46	18.34	14.92	19.81	44.17	43.99	37.41	5.93
Total Assets	61.78	92.33	47.06	61.77	211.72	263.74	310.57	259.09	137.53
Current Liabilities
Accounts Payable	0.88	2.99	3.47	1.44	2.37	4.72	2.61	15.73	2.54
Short-Term Debt	6.24	3.10	0.88	32.40	0.25	2.50	0.00	0.00	0.00
Current Portion of Long-Term Debt	6.24	3.10	0.88	32.40	-	-	-	-	-
Accrued Liabilities	1.05	4.09	5.91	5.67	11.41	-	-	-	-
Deferred Revenue	0.00	0.00	0.00	14.53	3.21	5.63	0.81	0.77	3.34
Other Current Liabilities	3.54	2.90	8.91	18.43	11.41	9.80	8.96	6.02	2.98
Total Current Liabilities	11.35	16.47	14.11	57.87	17.23	22.66	12.37	22.52	8.86
Non-Current Liabilities
Long-Term Debt	3.47	9.56	43.18	5.07	23.69	12.94	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	55.00	55.00	0.00	0.00	0.00	9.54	9.47	0.29
Total Non-Current Liabilities	8.42	70.19	215.87	134.62	24.84	45.08	39.69	40.22	30.36
Total Liabilities	19.76	86.66	229.98	192.49	42.07	67.74	52.06	62.74	39.22
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-204.99	-234.81	-187.08	-133.34	-424.13	-328.37	-199.67	-95.76	-40.18
Accumulated Other Comprehensive Income	0.00	0.00	-187.08	-0.40	-0.01	0.00	0.18	-0.08	-0.07
Additional Paid-in Capital	247.01	240.49	4.16	2.63	593.78	524.36	457.99	292.19	0.80
Shares Outstanding	12.86	12.20	11.93	11.93	11.93	-	-	-	-
Total Stockholders' Equity	42.01	5.68	-182.92	-130.71	169.65	196.00	258.51	196.36	98.31
Total Liabilities & Equity	61.78	92.33	47.06	61.77	211.72	263.74	310.57	259.09	137.53

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Q32 Bio Balance Sheet

How much debt does Q32 Bio have?

Q32 Bio had total debt of $9.71M as of Dec 31, 2025, against $48.30M in cash and short-term investments. Its debt-to-equity ratio was 0.23. Total debt was $12.65M a year earlier.

What are Q32 Bio's total assets?

Q32 Bio reported total assets of $61.78M as of Dec 31, 2025, down 33.1% from $92.33M a year earlier. Total liabilities were $19.76M.

What is Q32 Bio's shareholders' equity?

Q32 Bio's shareholders' equity was $42.01M as of Dec 31, 2025, or about $3.27 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition